Carefusion Corp (CFN) 10-K Annual Report August 2011

Fiscal 2011 GAAP income from continuing operations of $291 million, or $1.29 per diluted share; adjusted income from continuing operations of $371 million, or $1.65 per diluted share

•

Fiscal 2012 adjusted diluted earnings per share (EPS) guidance range of $1.80 to $1.90; revenue growth of 3 to 5 percent over fiscal 2011 on a constant currency basis

SAN DIEGO, Aug. 8, 2011 – CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported results for the quarter and fiscal year ended June 30, 2011.

“Growth in our Infusion, Dispensing and Infection Prevention businesses, gross margin expansion and the benefit of strong spending controls drove double digit improvements in our adjusted operating earnings for the quarter and for the year,” said Kieran Gallahue, chairman and CEO. “We continue to make progress in optimizing our product portfolio and expanding our geographical footprint. We recently acquired pharmacy automation innovator Rowa, enabling us to expand our Pyxis platform outside the U.S.”

“Looking ahead to fiscal 2012, we will continue to leverage operational efficiencies and reduce complexity across our businesses to drive bottom line growth that outpaces our top line growth. We are expecting revenue growth in a range of 3 to 5 percent over fiscal 2011 results, representing an improvement over the 2 percent growth we had this year and acceleration over the low single digit growth rates we are seeing in the markets where we participate. For adjusted EPS we are guiding to a range of $1.80 to $1.90.”

CareFusion’s reported results compare to the quarter and fiscal year periods ended June 30, 2010.

Results from the company’s International Surgical Products (ISP) business, which had been included in the Medical Technologies and Services segment and was divested in April 2011, have been classified as discontinued operations in the accompanying financial tables. Reported results for continuing operations and comparisons to prior periods exclude the historical results of the ISP business.

The following information was filed by Carefusion Corp (CFN) on Monday, August 8, 2011 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

Please wait while we load the requested 10-K report or click the link below:

https://last10k.com/sec-filings/report/1457543/000119312511216592/d10k.htm

View differences made from one year to another to evaluate Carefusion Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Carefusion Corp.

Continue

Assess how Carefusion Corp's management team is paid from their Annual Proxy

Carefusion Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2011 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Material Contracts, Statements, Certifications & more

Carefusion Corp provided additional information to their SEC Filing as exhibits

Exhibit 10.18: Form Of Performance Stock Units Agreement

Exhibit 10.20: Form Of Restricted Stock Units Agreement

Exhibit 12.1: Computation Of Ratio Of Earnings To Fixed Charges

Exhibit 21.1: Subsidiaries Of Carefusion Corporation

Exhibit 23.1: Consent Of Independent Registered Public Accounting Firm

Exhibit 31.1: Certification Of Chief Executive Officer

Exhibit 31.2: Certification Of Chief Financial Officer

Exhibit 32.1: Certifications Of Chief Executive Officer And Chief Financial Officer

Ticker: CFN
CIK: 1457543
Form Type: 10-K Annual Report
Accession Number: 0001193125-11-216592
Submitted to the SEC: Tue Aug 09 2011 4:36:07 PM EST
Accepted by the SEC: Tue Aug 09 2011
Period: Thursday, June 30, 2011
Industry: Surgical And Medical Instruments And Apparatus